IT1311921B1 - Composti farmaceutici. - Google Patents

Composti farmaceutici.

Info

Publication number
IT1311921B1
IT1311921B1 IT1999MI000750A ITMI990750A IT1311921B1 IT 1311921 B1 IT1311921 B1 IT 1311921B1 IT 1999MI000750 A IT1999MI000750 A IT 1999MI000750A IT MI990750 A ITMI990750 A IT MI990750A IT 1311921 B1 IT1311921 B1 IT 1311921B1
Authority
IT
Italy
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Application number
IT1999MI000750A
Other languages
English (en)
Italian (it)
Inventor
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT1999MI000750A priority Critical patent/IT1311921B1/it
Application filed by Nicox Sa filed Critical Nicox Sa
Priority to PCT/EP2000/003237 priority patent/WO2000061549A2/en
Priority to JP2000610825A priority patent/JP2002541242A/ja
Priority to MXPA01010209A priority patent/MXPA01010209A/es
Priority to CA002370406A priority patent/CA2370406A1/en
Priority to EP00917074A priority patent/EP1192129A2/en
Priority to IL14563200A priority patent/IL145632A0/xx
Priority to KR1020017012971A priority patent/KR20020005671A/ko
Priority to PL00351241A priority patent/PL351241A1/xx
Priority to AU38200/00A priority patent/AU3820000A/en
Priority to CN00808855A priority patent/CN1356981A/zh
Priority to TR2001/02939T priority patent/TR200102939T2/xx
Priority to HU0200747A priority patent/HUP0200747A3/hu
Priority to BR0009701-2A priority patent/BR0009701A/pt
Publication of ITMI990750A1 publication Critical patent/ITMI990750A1/it
Priority to NO20014926A priority patent/NO20014926L/no
Application granted granted Critical
Publication of IT1311921B1 publication Critical patent/IT1311921B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C07C327/34—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups with amino groups bound to the same hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT1999MI000750A 1999-04-13 1999-04-13 Composti farmaceutici. IT1311921B1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT1999MI000750A IT1311921B1 (it) 1999-04-13 1999-04-13 Composti farmaceutici.
CN00808855A CN1356981A (zh) 1999-04-13 2000-04-11 药用化合物
MXPA01010209A MXPA01010209A (es) 1999-04-13 2000-04-11 Compuestos farmaceuticos.
CA002370406A CA2370406A1 (en) 1999-04-13 2000-04-11 Pharmaceutical compounds
EP00917074A EP1192129A2 (en) 1999-04-13 2000-04-11 Pharmaceutical compounds
IL14563200A IL145632A0 (en) 1999-04-13 2000-04-11 Pharmaceutical compounds
PCT/EP2000/003237 WO2000061549A2 (en) 1999-04-13 2000-04-11 Pharmaceutical compounds
PL00351241A PL351241A1 (en) 1999-04-13 2000-04-11 Pharmacological compounds
AU38200/00A AU3820000A (en) 1999-04-13 2000-04-11 Pharmaceutical compounds
JP2000610825A JP2002541242A (ja) 1999-04-13 2000-04-11 医薬化合物
TR2001/02939T TR200102939T2 (tr) 1999-04-13 2000-04-11 Farmasötik bileşikler
HU0200747A HUP0200747A3 (en) 1999-04-13 2000-04-11 Pharmaceutical compounds and pharmaceutical compositions containing them
BR0009701-2A BR0009701A (pt) 1999-04-13 2000-04-11 Compostos ou sais, ou suas composições, uso dos mesmos, e, formulações farmacêuticas
KR1020017012971A KR20020005671A (ko) 1999-04-13 2000-04-11 약학적 화합물
NO20014926A NO20014926L (no) 1999-04-13 2001-10-10 Farmasöytiske forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000750A IT1311921B1 (it) 1999-04-13 1999-04-13 Composti farmaceutici.

Publications (2)

Publication Number Publication Date
ITMI990750A1 ITMI990750A1 (it) 2000-10-13
IT1311921B1 true IT1311921B1 (it) 2002-03-20

Family

ID=11382682

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI000750A IT1311921B1 (it) 1999-04-13 1999-04-13 Composti farmaceutici.

Country Status (15)

Country Link
EP (1) EP1192129A2 (zh)
JP (1) JP2002541242A (zh)
KR (1) KR20020005671A (zh)
CN (1) CN1356981A (zh)
AU (1) AU3820000A (zh)
BR (1) BR0009701A (zh)
CA (1) CA2370406A1 (zh)
HU (1) HUP0200747A3 (zh)
IL (1) IL145632A0 (zh)
IT (1) IT1311921B1 (zh)
MX (1) MXPA01010209A (zh)
NO (1) NO20014926L (zh)
PL (1) PL351241A1 (zh)
TR (1) TR200102939T2 (zh)
WO (1) WO2000061549A2 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
NZ519781A (en) 1999-12-23 2004-04-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
DE60131537T2 (de) 2000-06-22 2008-10-23 Nitromed, Inc., Lexington Nitrosierte und nitrosylierte taxane, zubereitungen und methoden der verwendung
WO2002060378A2 (en) 2000-12-21 2002-08-08 Nitromed, Inc. Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
JP2004528337A (ja) 2001-05-02 2004-09-16 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化ネビボロール、ならびにその代謝産物、組成物、および使用方法
AU2003248642A1 (en) 2002-06-11 2003-12-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
JP2005539089A (ja) 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
AU2003261281A1 (en) 2002-07-29 2004-02-16 Nicox S.A. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
KR20050083971A (ko) * 2002-11-22 2005-08-26 더 존스 홉킨스 유니버시티 인지능 손상의 치료를 위한 표적
US20090131342A1 (en) * 2004-01-22 2009-05-21 Nitromed, Inc. Nitrosated and/or nitrosylated compounds, compositions and methods of use
KR100678287B1 (ko) 2005-06-23 2007-02-02 한미약품 주식회사 클로피도그렐의 제조방법 및 이에 사용되는 중간체
CN100404543C (zh) * 2006-09-21 2008-07-23 浙江海正药业股份有限公司 一种合成吡利霉素的中间体及其制备方法和用途
US20120115824A1 (en) * 2009-04-17 2012-05-10 Vidasym, Llc Vitamin D Receptor Agonists and Uses Thereof
US9598383B2 (en) * 2013-06-26 2017-03-21 The Regents Of The University Of California Reactive oxygen species-based prodrugs
CN107418989A (zh) * 2017-08-21 2017-12-01 浙江工业大学 一种脂肪酶催化在线合成n‑(5‑蔗糖酯戊酰基)美托洛尔的方法
CN113209065B (zh) * 2021-03-29 2023-06-20 中国科学院西北高原生物研究所 生物碱化合物在制备预防和/或治疗心脏损伤的产品中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1134458B (it) * 1980-11-26 1986-08-13 Real Sas Di Alberto Reiner Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
IT1190987B (it) * 1982-09-07 1988-02-24 Pharma Edmond Srl Tioesteri dell'acido acetilsalicilico,procedimento per la loro preparazione e composizioni farmaceutiche che li conttengono
ES8609231A1 (es) * 1985-12-03 1986-09-01 Farmhispania Procedimiento de obtencion del n-acetil-3(2-(acetiloxi)ben- zoilmercapto)alanina
IT1213301B (it) * 1986-07-14 1989-12-20 Zambon Spa Composizioni per il trattamento del le sindromi da ischemia e riperfusione
DE59712694D1 (de) * 1997-04-18 2006-08-24 Fritz Stanislaus Stabilisiertes arzneimittel enthaltend cysteinylderivate

Also Published As

Publication number Publication date
WO2000061549A3 (en) 2002-01-03
HUP0200747A2 (en) 2002-06-29
AU3820000A (en) 2000-11-14
BR0009701A (pt) 2002-04-02
NO20014926L (no) 2001-12-13
JP2002541242A (ja) 2002-12-03
KR20020005671A (ko) 2002-01-17
EP1192129A2 (en) 2002-04-03
IL145632A0 (en) 2002-06-30
TR200102939T2 (tr) 2002-09-23
HUP0200747A3 (en) 2003-02-28
CN1356981A (zh) 2002-07-03
ITMI990750A1 (it) 2000-10-13
NO20014926D0 (no) 2001-10-10
MXPA01010209A (es) 2003-07-21
CA2370406A1 (en) 2000-10-19
WO2000061549A2 (en) 2000-10-19
PL351241A1 (en) 2003-04-07

Similar Documents

Publication Publication Date Title
TR200000520A3 (tr) 4-Fenil-piridin türevleri.
MXPA03001425A (es) Compuestos farmaceuticos.
NO20022606D0 (no) Farmasöytiske kombinasjoner
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
IT1311921B1 (it) Composti farmaceutici.
NO20015510L (no) Medikament for lokal påföring
DE60029755D1 (de) Congawandschutz.
NO20016430L (no) Farmasöytisk kompleks
HK1046133A1 (en) Pharmaceutical compounds.
ES1044451Y (es) Gavion perfeccionado.
ES1043296Y (es) Mosquero perfeccionado.
ES1043697Y (es) Contenedor-expositor perfeccionado.
ES1042294Y (es) Envase perfeccionado.
ES1044951Y (es) Tabique perfeccionado.
ES1044838Y (es) Friegasuelos.
ES1044558Y (es) Sandalia perfeccionada.
ES1041633Y (es) Racor perfeccionado.
ES1044754Y (es) Acietera perfeccionada.
ES1044625Y (es) Garrafa perfeccionada.
ES1044307Y (es) Transelevador perfeccionado.
ES1043499Y (es) Tapa-soporte perfeccionada.
ES1041942Y (es) Piñata perfeccionada.
ES1044266Y (es) Carta-sobre perfeccionada.
ES1043536Y (es) Calzado perfeccionado.
ITRM20000199A0 (it) Formulazione.